No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
CKPT Checkpoint Therapeutics
- 3.180
- -0.150-4.50%
Close Jan 17 16:00 ET
- 3.190
- +0.010+0.31%
Post 19:56 ET
155.29MMarket Cap-1.74P/E (TTM)
3.370High3.150Low593.29KVolume3.350Open3.330Pre Close1.91MTurnover1.78%Turnover RatioLossP/E (Static)48.83MShares4.50052wk High-12.33P/B105.82MFloat Cap1.38052wk Low--Dividend TTM33.28MShs Float105.000Historical High--Div YieldTTM6.61%Amplitude1.300Historical Low3.213Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
This PG&E Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
D. Boral Capital Initiates Checkpoint Therapeutics(CKPT.US) With Buy Rating, Announces Target Price $9
Checkpoint Therapeutics Signs Executive Agreement With CFO
Checkpoint Therapeutics Insider Sold Shares Worth $1,076,412, According to a Recent SEC Filing
Lake Street Maintains Checkpoint Therapeutics(CKPT.US) With Buy Rating, Raises Target Price to $7
FDA Approves Checkpoint Therapeutics' Skin Cancer Drug One Year After Rejection
Heat List
US
Overall
Symbol
Price
% Chg
No Data